Fenofibrate 145 mg Tablet (Fibofen-145)
Fenofibrate 145 mg — Lipid-Lowering Tablet
| Composition | Fenofibrate 145 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Blister) |
| MRP | ₹ 1250 |
| Therapy | Cardiac + Diabetic — PPAR-alpha agonist (fibrate) |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
More in the Fibofen range from Trumac Healthcare
| Brand | Composition | Pack |
|---|---|---|
FIBOFEN-160 Tablet |
Fenofibrate 160mg Tablets | 10 x 10 (Blister) |
All available for PCD franchise on a monopoly basis and as wholesale stock. WhatsApp +91 90416 77932 for net rates.
For chemists, distributors and doctors: Fibofen-145 (fenofibrate 145 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
Buying this composition for PCD franchise, wholesale or under your own brand? See Fenofibrate 145 mg Tablet – manufacturer, supplier & PCD franchise for available packs and brand options.
See the full cardiac tablets range – manufacturer, supplier and PCD franchise: telmisartan, olmesartan, amlodipine, metoprolol, rosuvastatin, atorvastatin, clopidogrel, ticagrelor, trimetazidine and their combinations.
About Fibofen-145 Tablet
Fibofen-145 Tablet contains Fenofibrate 145 mg in a nanocrystalline formulation that provides good bioavailability with or without food. Fenofibrate is a peroxisome-proliferator-activated-receptor (PPAR)-alpha agonist with potent triglyceride-lowering and modest HDL-raising effects.
It is indicated for severe hypertriglyceridaemia, mixed dyslipidaemia, low-HDL states, diabetic dyslipidaemia and as adjunct to statins in patients with persistent triglyceride elevation.
Camrut Healthcare manufactures Fibofen-145 under WHO-GMP conditions for PCD pharma franchise across India.
Looking up another Trumac medicine? See what every Trumac Healthcare brand is used for – A–Z in English and Hindi: Trumac Healthcare tablet uses. Take medicines only as your doctor prescribes.
Indications
- Severe hypertriglyceridaemia (TG > 500 mg/dL)
- Mixed dyslipidaemia
- Low HDL cholesterol with high triglycerides
- Diabetic dyslipidaemia
- Adjunct to statins in residual hypertriglyceridaemia
Mechanism of Action
Fenofibrate activates PPAR-alpha, a nuclear transcription factor regulating lipid metabolism genes. This increases lipoprotein lipase activity (clearing triglyceride-rich particles), decreases apoC-III (an LPL inhibitor) and increases apoA-I synthesis (raising HDL). Net effects: 30–50% reduction in triglycerides and modest 5–20% increase in HDL.
Dosage & Administration
- Adults: 1 tablet (145 mg) once daily, with or without food
- Take with adequate water
- Monitor lipids every 3 months
- Periodic monitoring of liver function and CK
Side Effects
- Mild GI upset
- Myalgia and muscle weakness
- Elevated liver enzymes
- Increased serum creatinine
- Cholelithiasis with prolonged use
Contraindications & Precautions
- Severe hepatic impairment
- Severe renal impairment (eGFR < 30)
- Pre-existing gallbladder disease
- Hypersensitivity to fenofibrate
- Pregnancy and breastfeeding
Storage
Store below 25°C.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare cardiac diabetic PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Fibofen-145 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products

FIBOFEN-160 Tablet